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ABSTRACT 
The influence of intracranial pressure, systemic arterial 
pressure and cerebral perfusion pressure upon the development of 
vasogenic cerebral oedema is largely unknown. To study their 
relationship, an osmotic disruption of the blood-brain barrier 
was produced unilaterally in female rabbits by injecting 1 cc/Kg 
of 2 M Na Cl into the left internal carotid artery. The amount 
of vasogenic oedema produced was assessed by quantitation of the 
amount of Evans Blue extravasation into the area of maximum blood-
brain barrier breakdown by optical densitometry following Formamide 
extraction of the Evans Blue from the oedematous cortex. Intra-
cranial pressure was measured using a cisterna magna catheter into 
which mock CSF could be infused to a predetermined pressure. Sys-
temic arterial pressure was controlled by exsanguination from a 
femoral artery catheter in those animals selected for blood pressure 
control. 
In the initial 18 animals in which blood pressure was not 
controlled, no significant relationship between the intracranial 
pressure and the degree of Evans Blue extravasation was noted. 
In these animals, however, a significant direct relationship 
between cerebral perfusion pressure (defined as mean arterial 
pressure minus mean intracranial pressure) and Evans Blue 
extravasation was found (correlation coefficient= .630, p < .001). 
When intracranial pressure was maintained constant at 0-5 mmHg 
in 16 animals and different levels of blood pressure were pro-
duced by exsanguination, a significant direct relationship 
III 
between Evans Blue extravasation and the systemic arterial 
pressure was found (correlation coefficient= .786,p <.001). 
In 20 animals the blood pressure was maintained constant 
at 90-100 mmHg and the intracranial pressure was varied between 
0, 25, 50 and 75 mmHg with five animals at each pressure. There 
was a significant correlation indicating increasing Evans Blue 
extravasation at low levels of intracranial pressure (p (.001). 
This relationship may be exponential. 
Cerebral blood flow determinations by the H
2 
clearance 
method indicated loss of autoregulation in the areas of brain 
injured by the intracarotid hypertonic saline. In addition, a 
progressive fall in the cerebral blood flow with time was noted 
in the same areas. Electron microscopic studies of cortical 
samples demonstrated abnormal amounts of extracellular fluid 
in the neuropil surrounding capillaries, and swelling of astro-
cytic foot processes. Inter-endothelial tight junctions were 
not disrupted. 
These results indicate a high systemic arterial pressure 
and low intracranial pressure (i.e.a large cerebral perfusion 
pressure) promote Evans Blue extravasation in this model of 
blood-brain barrier disruption. This finding has implications 
for the management of patients with vasogenic oedema. Vigorous 
control of intracranial hypertension and/or failure to treat 
systemic arterial hypertension may have detrimental consequences 
by promoting increased cerebral oedema. 
IV 
PREFACE 
This study arose out of a desperate situation I have been 
faced with on several occasions immediately following evacuation 
of an acute subdural haematoma. Having safely accomplished the 
haematoma removal, on these occasions the brain began to swell 
relentlessly and uncontrollably minute by minute filling and 
then exuding out of the craniotomy defect. In this situation 
the choice was to either remove large amounts of swollen brain 
or close up the head and allow the patient to die. A similar 
situation arose once in my experience after the successful removal 
of a huge leftsphenoidwing meningioma in a 45 year old woman 
who presented with a VI nerve palsy as her only sign. The rela-
tively straight-forward operation resulted in the patient 
initially awakening neurologically intact. Within 24 hours she 
began to deteriorate and eventually died of massive left hemis-
phere swelling. 
In explaining this phenomenon, it seemed that removal of a 
compressing mass overlying an area of brain in which the blood-
brain barrier was disrupted may promote oedema formation within 
that area of brain. This could possibly occur by either a direct 
hydrostatic effect or by allowing increased blood flow into the 
area. If this were the case, then a similar situation might 
also arise in the patient with a diffusely injured brain, swollen 
with oedema, in whom the intracranial pressure was iatrogenically 
lowered by the venting of CSF from a ventricular catheter. CSF 
venting is currently recommended for such patients with 
v 
intracranial hypertension in the belief, yet unproven, that a 
lower intracranial pressure may help the patient by reducing 
brain shift and increasing cerebral blood flow. I questioned 
if artificially reducing the intracranial pressure may in fact 
be detrimental to the injured brain by leading to further brain 
oedema. This study was initially designed to investigate the 
influence of intracranial pressure on brain oedema development. 
As the study progressed, however, I found that not only intra-
cranial pressure but also the systemic arterial pressure and 
the derived cerebral perfusion pressure were directly related 
to cerebral oedema formation. 
The study was undertaken during my neurosurgical residency 
at the University of Western Ontario, London, Ontario, Canada. 
The time spent working on the research project was considered part 
of my training by the Royal College of Surgeons of Canada. The 
laboratory experiments were performed in the Brain Research 
Laboratory, Victoria Hospital and the Cerebral Blood Flow Labora-
tory, University Hospital, University of Western Ontario. In 
addition to the guidance of Assistant Professor R. F. Del Maestro, 
M.D., PhD., FRCS(C) I wish to acknowledge the assistance of 
Associate Professor A. L. Amacher, M.D., FRCS(C), for help in 
formulating the study and Associate Professor J. K. Farrar, PhD., 
Department of Biophysics, for teaching me the hydrogen-clearance 
technique of cerebral blood flow analysis. I also wish to 
acknowledge the assistance of Messrs. W. MacDonald, BSc and 
VI 
P. Floyd, BSc for technical assistance in spectrophotometric 
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Unlike the lung or soft tissue of the limbs where oedema 
may develop consequent upon such problems as hypoalbuminaemia 
or cardiac failure, oedema of the brain occurs only as a con-
sequence of a primary injury or disease process. Free entry 
of intravascular fluid, metabolites and protein into the brain 
is prevented by the "blood-brain barrier", an anatomical and 
physiological barrier. Histological study has shown the blood-
brain barrier 'to be at the level of the cerebral capillary 
endothelium. (24). Unlike endothelium elsewhere in the body, 
the cerebral capillary endothelial cells are connected by 
continuous tight junctions. In addition, fenestrations, trans-
endothelial channels and pinocytotic vesicles present in endo-
thelial cells elsewhere are rarely demonstrated. Movement of 
metabolites such as glucose and amino acids across the blood-
brain barrier is dependent upon their lipid solubility, molec-
ular size and the presence of specific carrier-mediated trans-
port systems. (23). 
Cerebral oedema may develop when the blood-brain barrier 
is disrupted. It has been categorized into three types; 
vasogenic, cytotoxic and transcellular. In vasogenic oedema, 
the primary pathological process is disruption (by either 
anatomical or physiological means) of the blood-brain barrier 
allowing entry of intravascular components (protein, water) 
into the cerebral extracellular space. Vasogenic oedema may 
2 
develop as the consequence of tumour, trauma, infection or from 
drug induced blood-brain barrier breakdown. (26). 
In cytotoxic oedema, disturbances of cellular metabolism 
(for example resulting from anoxia) result in loss of water and 
ion hemeostasis at the cellular level with consequent fluid 
entry into the cell and resultant cellular swelling. Trans-
cellular oedema arises in hydrocephalus when ventricular fluid 
under increased pressure moves by bulk flow from the ventricle 
into the cerebral extracellular space. 
Cerebral oedema leads to brain swelling and shifting with-
in the cranium, cerebral ischaemia and elevated intracranial 
pressure. In addition, experimental evidence suggests that 
oedema fluid or its effects within the cerebral extracellular 
space may be harmful to the neuropil. (4, 10). 
Recent reported advances in the management of patients 
with vasogenic cerebral oedema and brain swelling from trauma 
have stressed the necessity to control intracranial pressure 
(ICP) to near normal levels. (18, 20, 27). The aim of this 
treatment is two-fold: (1) to prevent shift of the brain down-
ward through the tentorial hiatus (herniation) and thus reduce 
pressure on the vital brain stem centers and (2) to improve 
cerebral blood flow inside the head by improving the cerebral 
perfusion pressure. However, the effect of control of the 
intracranial pressure on brain oedema formation in man is 
unkown. According to Starling's Law manipulation of the 
3 
intracranial pressure might be expected to influence movement of 
intravascular fluid across a disrupted blood-brain barrier. (15). 
All neurosurgeons at some time have seen the development of 
rapid (within minutes) uncontrollable brain swelling from cerebral 
oedema following acute decompression of an injured brain by the 
evacuation of an acute subdural haematoma. This brain swelling 
can also be seen rarely following removal of a large meningioma. 
The phenomenon has been termed "malignant" cerebral oedema. The 
progressive swelling over the ensuing 1 to 12 hours often leads 
to the patient's demise. In animals subjected to an acute cryogenic 
brain injury, decompressive craniectomy over the injury site has 
been shown to increase local cerebral oedema formation. (7). 
This study was initially undertaken to investigate this 
phenomenon of increased brain oedema formation occasionally 
seen following removal of a cerebral compressive lesion. It 
investigates the hypothesis that elevated intracranial pressure 
(either local as in the case of a haematoma, or generalized 
as the result of a diffuse brain injury with swelling) may 
retard movement of oedema fluid across a disrupted blood-
brain barrier, and thus reduce vasogenic oedema formation. 
As the study progressed, it became clear that the systemic 
art erial pressure may also significantly influence cerebral 
oedema formation. Again applying Starling's Law, it is reason-
able to hypothesize that variations in the cerebral intra-
vascular hydrostatic pressure in areas of brain in which the 
4 
blood-brain barrier has been disrupted may lead to increased 
vasogenic oedema. 
In normal brain, cerebral autoregulation maintains the 
cerebral blood flow and capillary hydrostatic pressure constant 
between a wide range of systemic arterial pressures, if the 
intracranial pressure is constant. (Figure 13)(21). This phenom-
enon is called autoregulation. Diseases which disrupt the blood-
brain barrier (e.g. trauma, ischaemia) may lead to disordered 
autoregulation. In this situation, variations in the blood 
pressure are reflected by variations in the cerebral capillary 
hydrostatic pressure. If the amount of fluid flowing across the 
disrupted blood-brain barrier were to vary, then alterations in 
vasogenic oedema formation would presumably occur. Some evidence 
already exists in animals subjected to traumatic or ischaemic 
brain injury that increased blood pressure may be associated with 
an increase in vasogenic oedema formation. (6, 16, 19, 26). In 
humans with brain injury, the effect of blood pressure changes on 
cerebral oedema development has not been investigated. It may be 
an important factor to be considered in the management of brain-
injured patients. Of additional importance is that therapy with 
induced hypertension has become part of the standard treatment for 
certain types of cerebralischaemiaincluding ischaemia from 
vasospasm resulting from subarachnoid hemorrhage. (13). If in this 
situation blood-brain barrier disruption has already occurreq, 
induced hypertension may be harmful to the patient by promoting 
5 
further oedema formation. 
This study has been undertaken with rabbits to ascertain 
the influence of various levels of both the intracranial 
pressure, the systemic arterial pressure and the derived cerebral 
perfusion pressure (defined as mean arterial pressure minus mean 
intracranial pressure) (21) upon the development of vasogenic 
cerebral oedema. A relatively pure model of vasogenic cerebral 
oedema can be produced in animals by osmotic disruption of the 
blood-brain barrier by the direct injection of hypertonic saline 
into the internal carotid artery of a rabbit. (8, 9). Disruption 
of the blood-brain barrier is produced within five minutes of 
injection by a direct effect of the hypertonic saline upon the 
capillary endothelium. (11). The period immediately following 
blood-brain barrier disruption is an ideal time to investigate 
the relationship of the blood pressure and intracranial pressure 
upon oedema formation. As a marker for the amount of oedema 
formation, experimental studies in animals have shown that Evans 
Blue is ideal because of its immediate complete binding to albumen 
following intravenous injection. (29). Thus, it will only enter 
into the extra-vascular space when the blood-brain barrier has 




MATERIALS AND METHODS 
Because of their proven reliability for studying hypertonic 
saline cerebrovascular injury and cerebral oedema, rabbits weigh-
ing 2.3 - 2.8 kg were selected. Females were used because evidence 
exists that there are different permeability characteristics of 
the blood-brain barrier of male and female rabbits. An anaesthetic 
agent that provided an anaesthetized immobile and physiologically 
stable animal initially breathing spontaneously was sought. After 
attempts at using Ketamine alone (which failed to anaesthetize the 
animal in about 20 percent of cases) intramuscular Pentobarbital, 
and inhalational agents (which resulted in frequent death from 
cardiorespiratory arrest), a combination of Ketamine Hydrochloride 
(Ketalar) 100 mg/kg and Xylazine (Rompun) 10 mg/kg, intramuscular 
was found to consistently provide satisfactory anaesthesia. In 
addition, once attached to a ventilator the animal did not fight 
ventilation. 
All incision lines were infiltrated with .5% Lidocaine 
(Xylocaine, Astra) to reduce the amount of general anaesthetic 
required. Fifteen minutes later, the animal was turned prone, its 
head placed in a headholder and the atlanta-occipital membrane was 
exposed via a mid-line incision. Following complete haemostasis, 
the membrane and arachnoid were incised just below the foramen 
magnum and a PE-60 Intramedic polyethylene catheter inserted 2-3 mm 
into the cisterna magna with the end lying free in the sub-arachnoid 










Method of measurement and elevation of the intracranial pressure 
(ICP) via a cisterna magna catheter. The rate of the infusion 
pump was adjusted to infuse normal saline at 37° to produce the 
desired ICP. 
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a muscle plug into the hole beside the catheter. The catheter 
was secured in position with acrylic glue. The catheter was then 
attached to a Statham (Statham Laboratories, Inc., Puerto Rico) 
pressure transducer (#1) via a three-way stop-cock allowing simul-
taneous recording of the intracranial pressure (ICP) and the 
infusion of 0.9% normal saline at 37° C. when required to elevate 
the IC~ (Fig. 1). The animal was then turned supine, and via 
a mid-line neck incision, a tracheostomy and left external jugular 
venous catheter with normal saline running at 5 cc per hour were 
inserted. The animal was then attached to a volume-cycled venti-
lator and the rate and tidal volume adjusted to ventilate the 
rabbit to a Paco
2 
of 39 ± 4 mmHg. The left common, internal and 
external carotid arteries were exposed, and the external carotid 
artery ligated with 3-0 silk close to the bifurcation. (Fig. 2). 
The common carotid artery was then ligated 1 em proximal to the 
bifurcation, and a PE-60 catheter attached to a Statham pressure 
transducer (#2) inserted into the distal common carotid artery 
for measurement of stump pressure and when required, the simul-
taneous infusion of 2.0 M NaCl to produce blood-brain barrier 
breakdown. A third PE-60 catheter attached to a Statham pressure 
transducer (#3) was inserted into the proximal common carotid 
artery to allow systemic arterial pressure (SAP) measurement and 




and pH. The three Statham pressure 
transducers were attached to a Gould (Gould Inc., Cleveland, OH) 




The method used to perfuse the rabbit left internal carotid 
artery territory with 1 cc/kg 2M Na Cl at a pressure 15-30 mmHg 
higher than systemic arterial pressure. The time taken to 






FIGURE 3a, b 
Superior (a) and inferior (b) views of a typical left hemisphere 
lesion demonstrating Evans Blue extravasation. Note also some 
extravasation into the right anterior cerebral territory. 
r ~ 
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the three pressures. (Figs. 4 & 6). 
The left femoral artery was exposed and cannulated to allow 
removal of blood in those animals selected for blood pressure 
control. All arterial catheters were kept patent with the slow 
infusion of heparinized normal saline solution. 
The experiment was then conducted in three stages. In the 
first stage, the influence of increased ICP (without the SAP being 
controlled) upon cerebral oedema development was investigated. 
Eighteen animals were used to study the effect of 3 randomly 
allocated levels of ICP (6 animals each at 0, 25 and 50 mmHg) 
upon oedema formation as measured by Evans Blue (EB) extravasation 
in the cortex. Blood-brain barrier disruption was produced by 
infusing 1 cc/kg of 2.0 M Na Cl into the left internal carotid 
artery. (Fig. 3). Because elevated cerebral arterial pressure has 
been shown to disrupt an intact blood-brain barrier (25) the 
injection pressure was restricted to 15-30 mmHg above the SAP. 
The brains of the rabbits studied weighed 6-8 gms. If the average 
cerebral blood flow (CBF) is assumed to be 50 ml per 100 gram 
per minute, the rabbit brain normally receives only 3-4 cc per 
minute of blood. Approximately 1/3 i~ supplied by each internal 
carotid artery. At initial trials, 1 cc/kg of 2.0 M Na Cl solution 
was found to produce a consistent reproducible disruption of the 
blood-brain barrier. Infusion of that volume of hypertonic saline 
at 15-30 mmHg greater than SAP takes approximately 40-60 seconds. 

















0 I =JINfWi I 
10 MIN 
Tracings of the stump, systemic arterial (SAP) and intracranial 
(ICP) pressures from a first stage animal with the ICP elevated 
to 50 mmHg. Note the large reflex increase in stump pressure 
and SAP in response to intracarotid hypertonic saline injection 
and ICP elevation. 
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immediately elevated to the predetermined level (0, 25 or 50 mmHg) 
by infusing 0.9% NaCl at 37° C. intracranially via the cisterna 
magna catheter using a Sage (Orion Research Inc., Cambridge, Ma) 
infusion pump. (Fig. 4). Upon reaching the desired ICP, 2 cc/kg 
of 2 gm/100 ml Evans Blue (Fisher Scientific, Fair Lawn, New Jersey) 
in distilled water (0.270 Osm) was injected intravenously. The 
ICP was then kept at the desired level for 10 minutes, arterial 
blood gases were drawn, and the animal was sacrificed by injecting 
a bolus of intravenous air. Both external jugular veins were 
then cut, the right atrium opened and 100 cc of 0.9% Na Cl infused 
into the left internal carotid catheter by gravity at 100 em of 
water pressure to flush out the cerebral intravascular contents. 
(8, 9). The brain was then removed, examined and the area and 
degree of EB extravasation recorded. (Fig. 3). This was always 
maximum in the cerebral cortex. 
The amount of oedema was measured by quantitation of the 
amount of EB extravasation into the cortex. 0.10 to 0.15 gm of 
cerebral cortex was removed from the area of greatest EB extrava-
sation (the lesion) and from an identical area in the opposite 
hemisphere (the control). The samples were then cut into quarters 
and soaked in 1 cc of Formamide (Fisher Scientific, Fair Lawn, 
New Jersey) for 72 hours to extract the EB. This method of EB 
extraction was originally described by Nachman. (22). More 
recently it was used by Ackerman in studying blood vessel· perme-
ability in liver tumors. (21). The fluid containing the extracted 
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EB was then removed and the optical density measured at 620 nm 
using a Perkin-Elmer 559A double beam spectrophotometer (Perkin-
Elmer, Oak Brook, IL) with Formamide in the reference cuvette. (Fig. 5) 
A standard curve was prepared using EB diluted in Formamide 
and the results expressed aspgm EB/gm cortical weight. The amount 
of EB crossing the blood-brain barrier was assessed by subtracting 
the EB extracted from the control sample from that extracted from 
the lesion sample. This method of EB extraction and quantitation 
by optical densitometry has not previously been used for the study 
of cerebral oedema. 
The second stage of the experiment consisted of maintaining 
the ICP constant (at 0-5 mmHg) after infusion of the hypertonic 
intracarotid saline and then altering the SAP in each animal to 
a predetermined level by exsanguination from the femoral artery 
catheter. This was achieved by drawing blood into a 50 cc hepara-
nised saline syringe as required to maintain the predetermined 
arterial pressure. Ten animals were studied and the range of 
randomly allocated mean SAP's was from 24-120 mmHg. The experi-
ment was otherwise identical to that of the first stage. 
The third stage of the experiment was identical to the 
first stage except that the SAP was kept at a constant mean level 
of 90-100 mmHg by the controlled removal of blood from the left 
femoral artery catheter, i.e. the hypertensive response (precipi-
tated by (i) the infusion of hypertonic intracarotid saline and 
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FIGURE 5 
Cortical samples soaked in 1 cc of Formamide for 72 hours. 
Left is from the lesion cortex showing distinct blue colouring 
of the Formamide caused by extracted Evans Blue. Right is from 
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10 MIN 
Tracings of the stump, systemic arterial (SAP) and intracranial 
(ICP) pressures from a third stage animal with the ICP elevated 
to 50 mmHg. The reflex increase in SAP has been prevented by 
controlled exsanguination. The SAP is kept constant at 
90-100 mmHg mean. 
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saline) was prevented. (Fig. 6). 
Twenty animals were studied in the 3rd stage with the ICP 
kept at 0, 25, 50 or 75 mmHg (five animals at each pressure level). 
18 
CHAPTER 3 
RESULTS OF OEDEMA QUANTITATION 
First Stage Protocol 
The systemic arterial pressure (SAP), intracranial pressure 
(ICP) and degree of Evans Blue (EB) extravasation from the first 
eighteen animals are recorded in Appendix 1. The variation in 
levels of SAP's should be noted because this parameter was not 
controlled in the first stage of the experiment. The mean and 
standard deviation of the EB extravasation are recorded in 
Table 1. As outlined in Chapter 2, the degree of oedema fluid 
is represented by the "lesion-control" values. 
ICP's of 0, 25, and 50 mmHg were not associated with a 
statistically significant difference in the amount of extrava-
sation of EB. The degree of EB extravasation at an ICP of 
50 mmHg tended to be less than that occurring at 0 or 25 mmHg. 
The cerebral perfusion pressure (CPP), which takes account of 
both the SAP and the ICP (see Page40), was then calculated for 
each animal five minutes after lesion creation and plotted 
against the lesion-control value for the EB extravasation. A 
significant linear relationship (correlation coefficient 
. 680, p < 0. 001) was found between the CPP and the degree of EB 
extravasation. (Fig. 7). The six animals which had an ICP of 
0 (* in Fig. i) appeared to show a possible linear relationship 
between the SAP and EB extravasation. To investigate this 
relationship an additional 10 animals with varying degrees of 
SAP between 24-120 mmHg were then studied (second stage). 
19 
TABLE 1 
Mean and standard deviation of the amount of Evans Blue (EB) 
extravasation into the cerebral cortex of the 18 first stage 
rabbits at an intracranial pressure (ICP) of 0, 25 or 50 mmHg. 
Systemic arterial pressure was not controlled. There is no 
statistical·ly significant difference between the lesion-
control values. 
Evans Blue Extravasation ~ gm EB) 
(gm cortex) 
ICP Lesion Control Lesion-Control 
0 + + + 142.7-60.7 36.5-16.5 106.2-56.7 
25 + 147.2-32.8 + 32.1-16.1 + 115.0-36.5 
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CEREBRAL PERFUSION PRESSURE (mmHg) 
FIGURE 7 
Results of the first stage protocol plotting Evans Blue (EB) 
extravasation against cerebral perfusion pressure. The 
correlation coefficient for these 18 animals is .630 and the 
relationship is significant, P <.001. The results of the 
six animals with an ICP of 0 are indicated by an asterisk. 
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Second Stage Protocol 
The results of the second stage experiments are tabulated in 
Appendix 2. The w·ide range of SAP's was produced by controlled 
exsanguination from the left femoral artery catheter. The degree 
of EB extravasation related to variations in SAP with the ICP kept 
constant at 0-S mmHg in the 16 (6 from the 1st stage) animals 
demonstrated a highly significant linear relationship (correlation 
coefficient = • 786, p< .001). Increasing SAP led to increasing 
EB extravasation. (Fig. 8). 
Third Stage Protocol 
In the third stage, 20 animals were randomly allocated to an 
ICP of 0, 2S, SO and 7S mmHg. The experiment was conducted as in 
the first stage except that the large rise in SAP which occurred 
in response to both the intra-arterial hypertonl.c saline injection 
and the elevated ICP was prevented by controlled exsanguination. 
(Fig. 6). The SAP of each animal was consequently maintained at 
90-100 mmHg. The values of EB extravasation for each of these 20 
animals are recorded in Appendix 3. The mean and standard deviation 
of the values from the five animals at each of the four ICP's are 
recorded in Table 2. The value at an ICP of 0 is significantly 
less than at ICP's of 2S, SO and 7S mmHg (p< .001). When plotted 
on a graph (Figure 9) the line of best fit may be curvilinear 
suggesting an exponential relationship between the ICP and the 
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SYSTEMIC ARTERIAL PRESSURE (mmHg) 
FIGURE 8 
Results of the second stage protocol plotting Evans Blue (EB) 
extravasation against systemic arterial pressure (SAP). The 
intracranial pressure was kept at 0-5 mmHg. The plots marked 
with an asterisk are from the six first stage protocol animals 
which had an ICP of 0. The linear correlation coefficient is 
.786 and is significant (P(.OOl). 
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TABLE 2 
Mean and standard deviation of the amount of Evans Blue (EB) 
extravasation into the cortical samples of the 20 third stage 
animals at four levels of intracranial pressure (ICP). The 
mean systemic arterial pressure was maintained at 90-100 mmHg. 
The degree of EB extravasation at an ICP of 0 is significantly 
less than at an ICP of 25, 50 or 75 mmHg. The results are plotted 
graphically in Figure 6. 
Evans Blue Extravasation ~ gm EB) 
(gm cortex) 
ICP Lesion Control Lesion-Control 
0 + 140.9-33.4 + 25.2-11.6 + 115.7-31.9 
25 + 62.4-52.8 + 24.3-18.3 + 38.2-36.0 
so + 32.8-14.6 + 16.8- 8.5 + 16.0-11.6 
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INTRACRANIAL PRESSURE (mmHg) 
Results of the third stage protocol plotting mean and 
standard deviation of Evans Blue (EB) extravasation against 
mean intracranial pressure (ICP). The systemic arterial 
pressure (SAP) was maintained constant at 90-100 rnmHg in 
these 20 animals. Five animals were randomly allocated 
at each ICP level of 0, 25, 50 and 75 rnmHg. EB extravasation 
at ICP = 0 is significantly less than at 25, 50 and 75 rnmHg 




CEREBRAL BLOOD FLOW AND HISTOLOGICAL STUDIES 
CEREBRAL BLOOD FLOW 
To better understand the pathophysiology of oedema formation 
produced by this method, measurement of cerebral blood flow (CBF) 
was undertaken in four animals in whom the intracranial pressure 
(ICP) was not elevated. A platinum needle electrode was inserted 
(Fig. 10) into the cortex of each hemisphere (middle cerebral artery 
distribution)and the CBF (as determined by the initial slope 
index) was measured by the hydrogen clearance technique described 
by Young. (30). This method of CBF measurement utilizes the prin-
ciple that dissolved hydrogen previously deposited within the 
cerebral interstitium (by having had the animal breathe hydrogen 
gas) will be "washed out" of the brain at a rate depending upon 
the CBF when the animal ceases breathing hydrogen. The con-
centration of H
2 
is measured by a quantitative polarographic 
technique using the principle that the oxidative reaction 
+ -
H2-~2H +2e 
generates electricity. A platinum electrode is inserted into 
the cerebral cortex, a calomel reference electrode is placed 
into muscle in the posterior neck, and a polarity of +350 mV 
placed across the two electrodes. The current generated by the 
platinum electrode linerarly estimates tissue H
2 
concentration. 
This method has been shown to correlate well with other methods 
of CBF measurement, including the c14 antipyrine autoradiographic 
h . d. . . h . . d 




























Diagram of platinum needle electrode inserted into cerebral 
cortex for measurement of cerebral blood flow (CBF). The 
wire is completely insulated from all structures except the 
cortex. The electrode is inserted with a microdrive and held 
firmly in position by dental cement placed into the skull 
opening. 
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clearance methods. (30). The advantages of the hydrogen clearance 
technique over these other methods include its ability to record 
CBF in any small area where a platinum needle can be inserted, it 
can be used for multiple flow determinations from the same area 
of brain, and it is not dependent on the absolute value of the 
H2 signal but the clearance rate of the H2 . Finally, it is an 
inexpensive method. 
Figure lldemonstrates three recordings of the H2 depletion 
(represented by the polarographic current) from the injured 
hemisphere of a rabbit. The blood flow responsible for each of 











the amount of tracer taken up by the tissue per 
unit time 
the quantity of tracer brought by the arterial 
inflow 
the arterial blood tracer concentration 
the venous blood tracer concentration 
In the situation where brain is already saturated with H
2 
(which has a partition coefficient approaching 1) the arterial 
tracer concentration when the animal ceases breathing H
2 
is 
assumed to be 0. The Fick equation can be thus solved for 
blood flow per unit volume, i ,e. : 






+ " " • " 200-
LESION 







RABBIT #3 LESION {LEFT! SIDE 
POST -LESION I 
CBF 
"' .. "' " + 
C.B.F. {ML/IOOgn/MINJ 
PRE-LESION 87 
POST -LESION I 27 





POST -LESION I 
{SAP = 65mmHg 
POST-LESION 2 
ISAP = 130mmHg 
PRE-LESION 
{SAP = 60mmHg 
POST -LESION 2 
CBF 
"" + +" 
5 ..,; 4 
>-------< 
I MINUTE 
Cerebral blood flow (CBF) recordings using the Hydrogen clearance 
technique of changes in CBF in the lesion cortex of a rabbit 
both before and after injection of hypertonic saline into the 
left internal carotid artery. Each CBF value is calculated from 
the initial slope index. Following hypertonic saline injection 
the left hemisphre CBF is greatly reduced (POST-LESION #1). 
Bbweve~, because of loss of autoregulation, hypertension induced 
by I.V. angiotensin (indicated on the SAP recording) results 
in a marked increase in the CBF (POST-LESION #2). 
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The blood flow can be estimated from the half life, T~, the 
time required by the H
2 
concentration to fall to ~ its original 
value. Therefore CBF (in ml/100 gm/min) = In(~) x 100 x 60 
T~ 1 1 
4192 
T~ 
This determination of the CBF is called the initial slope 
index. 
Measurements were taken of the CBF both before and after 
the intracarotid hypertonic saline injection, and the state of 
autoregulation was determined by the CBF measurement following 
induction of hypertension (by infusion of angiotensin 0.04 mM/ml 




All readings reported were those obtained from the platinum 
hydrogen electrode that was inserted into the middle cerebral 
artery territory of the left hemisphere. In all animals auto-
regulation (as determined by the lack of change in CBF in response 
to angiotensin-induced hypertension) was found to be intact 
before the hypertonic saline lesion was produced. The value of 
the CBF immediately before and after the hypertonic saline 
injection in four animals are recorded in Table 3. A reduction 
in CBF after the hypertonic saline lesion was produced was 
present in each of the animals. However, with animals 3 and 4, 
in response to angiotensin induced hypertension, the CBF was 
restored to its pre-lesion value, indicating loss of auto-
regulation in the lesioned hemisphere. This response to hyper-
tension was repeated in each of animals 3 and 4 to confirm its 
reproducibility. The change in the CBF related to the level 
of systemic arterial pressure for rabbit #3 is recorded graphi-
cally in Figure 9. Following cessation of the angiotensin in 
animals 3 and 4, the CBF returned to the pre-angiotensin level. 
However, as noted in Table 3, the CBF fell to an even lower 
value. Further studies in animals 3 and 4 demonstrated a pro-
gressive reduction in the CBF over the two hours following 
lesion creation. 
CBF studies were also recorded from the middle cerebral 
artery territory of the control hemisphere in animals 2, 3 and 4. 
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TABLE 3 
Cerebral blood flow (CBF) recordings (initial slope index) 
from four rabbits before and after intracarotid hypertonic 
saline injection. Post-lesion #1 CBF was taken within 10 
minutes of the injection with the animal normotensive. Post-
lesion #2 was taken in animals 3 and 4 following induction 
of hypertension by intravenous angiotensin. Post-lesion #3 
was obtained following restoration of normal systemic arterial 
pressure (SAP). A fall in the CBF was noted following hyper-
tonic saline lesion creation. CBF was restored to pre-lesion 
levels following angiotensin induced hypertension (rabbit #3, #4) 
indicating loss of autoregulation. With time, a progressive 



























No alteration occurred in the CBF before and after the left 
hemisphere lesion was created, or in response to angiotensin-
induced hypertension. This confirmed normal autoregulation 
in the unaffected control hemisphere. 
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HISTOLOGICAL STUDIES 
Histological specimens were taken from the lesion hemisphere 
ten minutes after lesion creation to ascertain the pathology of 
intra-arterial hypertonic saline induced oedema. For light micro-
scopic study, cortical samples were fixed in 20% formalin, eight 
micron paraffin sections were cut and stained with PTAH. 
Specimens were prepared for electron microscopy as described 
by Auer et. al. (2). Immediately following sacrifice of the 
animal, a solution containing 1% glutaraldehyde, 1% paraformal-
dehyde, 5% sucrose and 0.1 M sodium cacodylate buffer at pH 7.4 
was infused into the left internal carotid artery at a pressure 
of 100 em H
2
o for 20 minutes. This was followed by an infusion 
of an identical volume of a more concentrated solution containing 
2.5% glutaraldehyde and 2.0% paraformaldehyde. The brain was 
then removed and cortical samples taken from the area of maximum 
blood-brain barrier breakdown. These samples were post-fixed 
for 90 minutes in a solution containing 1% osmium tetroxide, 
0.1 M sodium phosphate at pH 7.3 and 5% sucrose. Samples were 
then soaked in 2% uranyl acetate (Fisher Scientific, Fair Lawn, 
NH) overnight, embedded in Spurr (Taab Laboratories, Reading, 
England) and examined with a Philips E.M.-201 electron microscope. 
Examination of the light microscopic sections demonstrated 
obvious per-capillary fluid extravasation. Thrombi were not 
seen in any vessels. There were no areas of haemorrhage present. 
(Fig. 12a). By electron microscopic examination, fluid was seen 
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FIGURE 12a 
Light microscopic picture taken from lesion cortex 10 minutes 
after hypertonic saline injection. Peri-capillary fluid extrava-
sation into neuropil is seen. Note vessels are patent. 
PTAH x 45. 
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to have collected under the capillary basement membrane and 
within the extra-cellular space. (Fig. 12b). Marked swelling 
of the astrocytic foot processes was also seen. Examination 
of tight junctions demonstrated no obvious disruption or dis-
continuity. (Fig. 12c). I was unable to quantitate pinocytotic 
vesicles or transendothelial channels, findings which have been 
described previously in other models of osmotic blood-brain 
barrier injury. (11). 
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FIGURE 12b 
Electron microscopic picture of the peri-capillary neuropil 
taken from the lesion cortex. Note the collection of fluid 
between the capillary endothelium and basement membrane 
( .. ) , and in the extra-cellular space of the neuropil ( ~ ) . 
V = intracytoplasmic fluid-filled vacuoles within astrocytic 
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FIGURE 12c 
Electron microscopic picture of intact capillary inter-endothelial 
tight junction from the lesion cortex (~). 1 =capillary 




Control of an elevated intracranial pressure (ICP) to a 
value of less than 20 mmHg by the use of surgical decompression, 
ventriculostomy with intermittent venting of CSF, osmotic 
diuresis and hyperventilation has become standard treatment for 
the head injured patient with brain swelling from contusion and 
oedema. (18, 20, 27). Theoretically, control of intracranial 
hypertension has two aims: to improve circulation to ischaemic 
areas of brain by increasing the cerebral perfusion pressure 
(implicit in this concept is the belief that there are areas 
of the brain in which the cerebral autoregulation is not function-
ing normally) and to reduce brain shift caused by focal areas 
of swelling and pressure. Despite some encouraging reports 
comparing patients who have undergone aggressive treatment of 
elevated ICP with patients rep.orted in earlier series in whom 
such aggressive treatment had not been instituted, no controlled 
trials confirming the benefits of aggressive control of intra-
cranial hypertension on the outcome from severe head injury 
have been reported. (18, 20). 
Brain swelling that occurs following a severe head injury 
may be the result of vasogenic oedema. (28). This is thought 
to develop because of physical disruption of the blood-brain 
barrier. (14, 26). In addition to producing brain swelling 
with its resulting effects on the ICP, brain shift and cerebral 
perfusion, the oedema fluid may have a direct toxic effect on 
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the neuropil. (4, 10). 
The effect of alteration of the ICP on the development of 
vasogenic cerebral oedema has not been fully investigated. Cooper 
et. al. reported a significant increase in local cerebral oedema 
in monkeys with a cold-induced cortical injury in whom the bone 
flap overlying the injury had been removed to provide a decom-
pression. (7). Much of this oedema may, however, have resulted 
from the effects of strangulation of the cortex by the margins 
of the craniotomy as the brain protruded through. Klatzo et. al. 
demonstrated that removal of CSF (with consequent lowering of 
the ICP) will promote clearing of oedema fluid from injured 
brain. (15). The lowered ICP promoted bulk flow of oedema fluid 
from the cerebral extracellular space into the ventricular system. 
The effect of lowered ICP on the actual formation of the oedema 
fluid at the capillary level was not studied however. 
Some evidence exists that variations in the systemic 
arterial pressure (SAP) may influence the formation and spread 
of cold-induced vasogenic cerebral oedema in animals. (6, 16, 19). 
Marshall et. al. showed that hypertension following gas percussion 
cortical injury in cats increased the amount of brain swelling 
from vascular congestion and oedema. (19). They attributed this 
effect to a loss of cerebral autoregulation leading to greater 
blood flow t~ the injured brain. 
Recently, Avery et. al. demonstrated blood-brain barrier 
disruption following an ischaemic injury in gerbils. (3). 
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Induction of hypertension in the post-ischaemic period in these 
animals resulted in a marked increase in the amount of Evans Blue 
leakage into the brain. 
To better delineate the influence of the SAP, ICP and the 
derived cerebral perfusion pressure (CPP), (defined as mean SAP-
mean ICP) (21) on the formation of vasogenic oedema demonstrated 
visually by Evans Blue (EB) extravasation, I studied a rabbit 
model initially described by Del Maestro and Arfors (8, 9). 
This method utilizes hypertonic saline injected into the internal 
carotid artery to disrupt the blood-brain barrier. The method 
results in rapid (within five minutes) oedema formation which 
may be demonstrated visually by EB extravasation. 
Histological studies of the cerebral cortex injured by 
hypertonic saline in this study demonstrated peri-capillary 
extra-cellular fluid and swollen astrocytic foot processes 
impinging upon the capillary lumen. (Fig.12a,b).These findings 
are typical of the vasogenic cerebral oedema described previously 
in association with traumatic brain swelling and brain tumors. 
(14, 28). Of note, no obvious disruption of the inter-endothe-
lial tight junctions was present. (Fig.l2c). The mechanisms by 
which osmotic injury may disrupt the blood-brain barrier have 
been elucidated by Houthoff et. al. (11). They demonstrated 
that rather than actually disrupting inter-endothelial tight 
junctions, osmotic injury seems to result in an increase in 
pinocytotic activity and possibly to an opening of trans-endothelial 
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channels. My findings would certainly lend support to the 
observations of Houthoff. 
Evans Blue is almost completely bound to albumin within 
the bloodstream immediately following intravenous injection. 
(29). Thus, measurement of interstitial EB provides an assess-
ment of protein extravasation in the oedema fluid. Although 
water content is the true index of brain oedema, a strong 
correlation between EB labelled albumin extravasation and brain 
water content has been found by others in areas of vasogenic 
cerebral oedema. (5). If extraction of EB from a sample of 
cortex could be performed, then quantitation of the passage of 
protein-laden oedema fluid and thus quantitation of vasogenic 
oedema would be achieved. Previous reports quantitating EB 
extravasation have relied upon visual grading to a 1+, 2+, 3+, 
4+ or similar scale. Demonstration by Nachman et. al. (22) 
and Ackerman (1) that EB can be completely extracted from skin 
or liver by incubation with Formamide provided an ideal method 
for accurate quantitation of cerebral oedema fluid in my rabbits. 
Incubation of the cortical samples containing extravasated EB 
in Formamide for three days resulted in complete extraction of 
the EB into t he Formamide. · The amount of EB could then be 
quantitated by optical densitometry~ (Fig. 5). 
The anatomical variation in the territory of supply of 
each carotid artery to the rabbit brain, and variation in the 
pressure at which the hypertonic saline is injected manually, 
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may account for a variation in the distribution of maximum blood-
brain barrier breakdown that was encountered in this model. Thus, 
brain specimens were selected from the cortex of the left hemisphere 
where maximal blood-brain barrier disruption was visualized. A 
control sample was taken from the identical area in the opposite 
right hemisphere, although this control hemisphere was occasionally 
seen to have some degree of EB extravasation (particulary in 
hypertensive animals). Subtraction of the EB extracted from the 
control sample from that extracted from the lesion sample corrected 
for any EB remaining intravascularly. Thus, a true value for 
interstitial EB (and thus vasogenic cerebral oedema) was derived. 
Intracranial pressure was elevated by the infusion of normal 
saline at 37° C. into the cisterna magna. (Fig. 1). This method 
has been shown to produce identical ICP elevation in both the 
infra and supratentorial compartments in normal dogs. (12). 
My study was initially undertaken to investigate the relation-
ship between intracranial hypertension produced by cisterna 
magna infusion of normal saline and the formation of vasogenic 
cerebral oedema. The results indicate that when the ICP is 
elevated with no attempt being made to control the SAP (which 
rises both in response to the injection of intracarotid hyper-
tonic saline and to the elevation of intracranial pressure), 
no significant effect upon the amount of EB extravasation is 
seen. (Table 1). However, a significant correlation between 
the CPP and the amount of the EB extravasation is p'resent, 
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(p < 0. 001) (Fig. 7). When the intracranial pressure is kept 
at 0-5 mmHg (i.e. a normal level) while manipulating the SAP 
to a different level in each animal, a highly significant 
relationship (p (.001) between increasing SAP and an increasing 
amount of EB extravasation in the area of blood-brain barrier 
disruption is found. (Fig. 8). This confirms previously 
reported findings in animals with cold-induced or traumatic 
cortical injury. (6, 19). 
When the SAP is maintained constant at 90-100 mmHg mean 
by using controlled exsanguination from the femoral artery 
catheter, a decrease in the amount of EB extravasation is 
seen with increasing ICP. (Fig. 9). The shape of the graph 
plotting EB extravasation against the ICP with the SAP kept 
constant may indicate an exponential relationship (i.e. low 
levels of ICP result in a much greater degree of extravasation). 
The forces acting across a cerebral capillary membrane 
and responsible for the flow of oedema fluid across the membrane 
when the blood-brain barrier is disrupted, is derived from 




L (Pplasma_ Ptissue _ ~ (IIplasma _ IItissue) 
L = hydrol:Lc conductivity of the endothelial membrane 
pplasma intravascular hydrostatic pressure 
ptissue extracellular hydrostatic pressure 
plasma . 
II = osmot1c pressure of plasma 
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IItissue . f . = osmot~c pressure o t~ssue 
~ = osmotic reflection coefficient 
Starling's Law predicts that an increase in EB extravasation 
meyresult from a high SAP and/or a low ICP (i.e. factors leading 
to an increased CPP). A low ICP results in a low Ptissue which 
acts to increase fluid movement across the capillary membrane. 
Similarly, a high Ptissue (caused by a high ICP) will result in 
decreased oedema formation. 
In normal brain, cerebral blood flow is maintained relatively 
constant at approxmiately 50cc/100gms/min between a mean CPP 
range of 50 and 150 mmHg. (21) (Fig. '13). This phenomenon is 
called autoregulation and probably arises by both myogenic and 
b 1 . h · Th Pplasma · 1 b · · h · meta o ~c mec an~sms. e ~n norma ra~n w~t ~ntact 
cerebral autoregulation should also remain constant between 
CPP's of 50 and 150 mmHg. Pressures above the upper limit of 
1 . . 11 d . . pplasma . autoregu at~on w~ pro uce an ~ncrease ~n , promot~ng 
increased movement of fluid across the capillary wall. This 
movement of fluid increases significantly if the blood-brain 
barrier is disrupted. If autoregulation is impaired, the 
pplasma will increase at lower levels of the CPP leading to 
increased cerebral oedema formation. Results of the study of 
CBF following osmotic blood-brain barrier disruption demonstrate 
that autoregulation has ceased to function normally (Chapter 4), 
supporting this hypothesis. Marshall et. al. also postulated 
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Relationship between cerebral perfusion pressure (CPP) and 
~erebral blood flow (CBF) in normal brain indicating auto-
regulation to both falling blood pressure ~) or increasing 
intracranial pressure (AJCP), (From Miller, J.D. et. al., 
see Reference 21). CBF is maintained until the CPP falls 
below 50 mmHg. 
100 110 
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formation resulting from hypertension in their cat model of 
percussion brain injury. (19). A lowering of the upper limit 
of autoregulation in other models of cerebral oedema has not 
been seen, however. (16). 
The marked increase in EB extravasation seen at low levels 
of ICP in the third stage of this experiment (Fig. 9) may 
possibly be related to two factors. Not only is Ptissue 
. plasma 
reduced when the ICP ls zero, but P (due to loss of auto-
regulation) is increased. In contrast, in the second stage only 
one factor, Pplasma, is altered, perhaps thus accounting for 
-
the linear relationship between EB extravasation and SAP. (Fig.S) 
Maintenance of a normal (or even elevated) SAP and control 
of intracranial hypertension are recommended for the management 
of patients with brain injury from trauma or ischaemia. (13, 20). 
The reason for this is the belief that they act in part to promote 
improved blood flow to ischaemic areas of brain. My study has 
not examined this important aspect of alteration of arterial and 
intracranial pressure. As noted in Chapter 4, however, a pro-
gressive decline in the CBF not accounted for by any significant 
change in the ICP was observed in the lesion hemisphere of the 
rabbits following hypertonic saline injection. (Table 3). 
This fall in the CBF could theoretically arise from the increased 
oedema fluid within the cortical interstitium leading to capi-
llary compression. Alternatively, the fall in CBF may have 





although these latter findings were not observed histologically 
in our specimens taken 10 minutes after injury. Whatever the 
cause, the reduction in CBF may well lead to secondary ischaemic 
cortical injury. 
The results of my study do indicate that changes in the 
systemic arterial and intracranial pressures influence oedema 
development. Although these results cannot be applied directly 
to humans, they do raise serious questions about current recom-
mended management of the patient with cerebral oedema. Perhaps 
automatic manipulation to reduce the ICP to a set figure 
(e.g. 20mmHg) as is currently accepted practice in many centers 
is harmful to the patient by increasing oedema and brain swelling 
and then paradoxically reducing the cerebral blood flow. If 
a patient has elevated ICP from brain swelling but appears unchanged 
clincially, then it may be better to leave the intracranial hyper-
tension untreated. If the patient does show signs of deterioration 
with the intracranial hypertension (e.g. dilating a pupil or 
demonstrating an extensor response to pain indicating transten-
torial herniation), then no one would argue that it should be 
treated. Similarly if the ICP climbs to a level where the CPP 
is reduced to the lower limit of normal autoregulation (50 mmHg) 
mean, then the risks of causing cerebral ischaemia increasffiand 
the ICP should probably be lowered to improve the CPP and increase 
the CBF. 
The question of what SAP level is best for the patient should 
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also be examined in the light of results of this study. Patients 
with a severe brain injury frequently are hypertensive despite 
having a normal ICP (i.e. the Cushing reflex is not acting). It 
would seem appropriate to lower the SAP to a normal level with 
anti-hypertensive agents to reduce cerebral oedema formation. 
Again, care must be taken not to induce cerebral ischaemia by 
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APPENDIX 1 
Values of ICP, SAP and CPP and Evans Blue (EB)extravasation 
obtained from the 18 first stage animals. 
Evans Blue Extravasation 
~ Gm EB) 
(gm cortex) 
Rabbit ICP SAP CPP Control Lesion Lesion-Control 
II (mmRg) (mmHg) (mmHg) 
1 50 70 20 12.2 20.8 8.6 
2 25 132 107 47.9 114.5 66.6 
3 50 123 73 22.3 64.8 42.5 
4 25 108 83 27.8 144.7 116.9 
5 50 127 77 8.7 153.4 144.7 
6 0 50 50 21.3 67.4 46.1 
7 0 131 131 13.7 137.5 123.8 
8 25 90 65 54.8 156.0 101.2 
9 25 103 78 29.2 186.2 157.0 
10 0 27 27 41.3 83.6 42.3 
11 50 110 60 55.2 126.9 71.1 
12 25 90 65 13.3 104.5 91.2 
13 50 135 85 11.3 171.5 160.2 
14 25 113 88 19.8 177.0 157.2 
15 0 111 111 52.0 199.5 147.5 
16 0 116 116 35.3 220.1 184.8 
17 50 137 87 54.9 120.4 65.5 
18 0 112 112 55.2 148.1 92.9 
ICP = mean intracranial pressure 
SAP = mean systemic arterial pressure 5 minutes after lesion 
CPP = cerebral perfusion pressure 5 minutes after lesion 
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APPENDIX 2 
~ Values of SAP and Evans Blue (EB) extravasation for the 10 
second stage animals. ., 
Evans Blue Extravasation 




Rabbit SAP Control Lesion Lesion-control 
~· 11 (mmHg) 
1 77 33.9 214.1 180.2 
~ 
2 57 15.3 98.8 83.5 
3 30 31.5 61.9 30.4 
.!,· 
4 70 39.7 82.4 42.7 
'1 
-\ 5 88 22.1 97.7 75.6 
6 103 19.8 127.2 107.4 
.. ~1 
7 92 45.1 151.1 106.1 
"" 8 40 13.8 20.7 6.9 
9 24 6.8 10.1 3.3 
' . 10 98 26.5 149.8 123.3 
SAP mean systemic arterial pressure 
~ ~ ~ 55 
> APPENDIX 3 
Values of ICP and Evans Blue (EB) extravasation from the 20 
'1 
~ third stage animals. 
Evans Blue Extravasation ~ gm EB) 
(gm cortex) 
\' 
". Rabbit ICP Control Lesion Lesion-control 
r, it (mmHg) 
1 50 13.2 45.5 32.3 
., 
2 50 23.8 38.2 14.4 
3 25 
A 
25.5 54.4 28.9 
4 50 26.5 35.9 9.4 
5 0 25.5 149.8 124.2 
4 
6 25 11.2 29.5 18.3 
1 
-I 7 0 19.3 183.3 . 164.0 
8 25 20.0 33.3 13.3 
9 50 14.9 36.7 21.8 
.>1 
.... 10 0 16.2 93.0 76.8 
11 25 9.8 29.3 29.5 
" -
12 50 5.5 7.5 2.0 
13 75 26.6 40.7 14.1 
14 75 8.7 16.4 7.7 
~ ~ 
15 75 54.0 47.5 6.5 
Y, 16 75 7.5 16.5 9.0 
17 75 5.5 9.1 3.6 
~ ' 
18 0 19.8 127.2 107.4 
.., (Cont'd. on next page) 
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Evans Blue Extravasation ~ gm EB) 
(gm cortex) 
Rabbit ICP Control Lesion Lesion-control 
If (mmHg) 
19 0 45.1 151.1 106.1 
20 25 55.0 155.4 101.4 
ICP = mean intracranial pressure 
